Publications
-
Control of somatic tissue differentiation by the long non-coding RNA TINCR.
Kretz M,
Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, Johnston D, Kim GE, Spitale RC, Flynn RA, Zheng GX, Aiyer S, Raj A, Rinn JL, Chang HY, Khavari PA.
Nature.
2013;
493
(7431):
231-5
-
Long noncoding RNAs: cellular address codes in development and disease.
Batista PJ,
Chang HY.
Cell.
2013;
152
(6):
1298-307
-
RNA SHAPE analysis in living cells.
Spitale RC,
Crisalli P, Flynn RA, Torre EA, Kool ET, Chang HY.
Nat Chem Biol.
2013;
9
(1):
18-20
-
Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock.
Rando TA,
Chang HY.
Cell.
2012;
148
(1-2):
46-57
-
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression.
Wang KC,
Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, Wysocka J, Lei M, Dekker J, Helms JA, Chang HY.
Nature.
2011;
472
(7341):
120-4
-
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters.
Hung T,
Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, Wang Y, Kong B, Langerød A, Børresen-Dale AL, Kim SK, van de Vijver M, Sukumar S, Whitfield ML, Kellis M, Xiong Y, Wong DJ, Chang HY.
Nat Genet.
2011;
43
(7):
621-9
-
Cytotopic localization by long noncoding RNAs.
Batista PJ,
Chang HY.
Curr Opin Cell Biol.
2013;
25
(2):
195-9
-
Rejuvenation of gene expression pattern of aged human skin by broadband light treatment: a pilot study.
Chang AL,
Bitter PH, Qu K, Lin M, Rapicavoli NA, Chang HY.
J Invest Dermatol.
2013;
133
(2):
394-402
-
SeqFold: genome-scale reconstruction of RNA secondary structure integrating high-throughput sequencing data.
Ouyang Z,
Snyder MP, Chang HY.
Genome Res.
2013;
23
(2):
377-87
-
The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus.
Gomez JA,
Wapinski OL, Yang YW, Bureau JF, Gopinath S, Monack DM, Chang HY, Brahic M, Kirkegaard K.
Cell.
2013;
152
(4):
743-54
-
A molecular signature for purified definitive endoderm guides differentiation and isolation of endoderm from mouse and human embryonic stem cells.
Wang P,
McKnight KD, Wong DJ, Rodriguez RT, Sugiyama T, Gu X, Ghodasara A, Qu K, Chang HY, Kim SK.
Stem Cells Dev.
2012;
21
(12):
2273-87
-
Active chromatin and noncoding RNAs: an intimate relationship.
Flynn RA,
Chang HY.
Curr Opin Genet Dev.
2012;
22
(2):
172-8
-
Chromatin isolation by RNA purification (ChIRP).
Chu C,
Quinn J, Chang HY.
J Vis Exp.
2012;
(61)
-
Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma.
Chisholm KM,
Wan Y, Li R, Montgomery KD, Chang HY, West RB.
PLoS One.
2012;
7
(10):
e47998
-
Genome-wide measurement of RNA folding energies.
Wan Y,
Qu K, Ouyang Z, Kertesz M, Li J, Tibshirani R, Makino DL, Nutter RC, Segal E, Chang HY.
Mol Cell.
2012;
48
(2):
169-81
-
High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validation.
Wu AR,
Kawahara TL, Rapicavoli NA, van Riggelen J, Shroff EH, Xu L, Felsher DW, Chang HY, Quake SR.
Lab Chip.
2012;
12
(12):
2190-8
-
Suppression of progenitor differentiation requires the long noncoding RNA ANCR.
Kretz M,
Webster DE, Flockhart RJ, Lee CS, Zehnder A, Lopez-Pajares V, Qu K, Zheng GX, Chow J, Kim GE, Rinn JL, Chang HY, Siprashvili Z, Khavari PA.
Genes Dev.
2012;
26
(4):
338-43
-
Systematic reconstruction of RNA functional motifs with high-throughput microfluidics.
Martin L,
Meier M, Lyons SM, Sit RV, Marzluff WF, Quake SR, Chang HY.
Nat Methods.
2012;
9
(12):
1192-4
-
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
Littlepage LE,
Adler AS, Kouros-Mehr H, Huang G, Chou J, Krig SR, Griffith OL, Korkola JE, Qu K, Lawson DA, Xue Q, Sternlicht MD, Dijkgraaf GJ, Yaswen P, Rugo HS, Sweeney CA, Collins CC, Gray JW, Chang HY, Werb Z.
Cancer Discov.
2012;
2
(7):
638-51
-
Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.
Lee CS,
Ungewickell A, Bhaduri A, Qu K, Webster DE, Armstrong R, Weng WK, Aros CJ, Mah A, Chen RO, Lin M, Sundram U, Chang HY, Kretz M, Kim YH, Khavari PA.
Blood.
2012;
120
(16):
3288-97
-
Direct lineage conversion of terminally differentiated hepatocytes to functional neurons.
Marro S,
Pang ZP, Yang N, Tsai MC, Qu K, Chang HY, Südhof TC, Wernig M.
Cell Stem Cell.
2011;
9
(4):
374-82
-
Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.
Alastalo TP,
Li M, Perez Vde J, Pham D, Sawada H, Wang JK, Koskenvuo M, Wang L, Freeman BA, Chang HY, Rabinovitch M.
J Clin Invest.
2011;
121
(9):
3735-46
-
Dynamic chromatin localization of Sirt6 shapes stress- and aging-related transcriptional networks.
Kawahara TL,
Rapicavoli NA, Wu AR, Qu K, Quake SR, Chang HY.
PLoS Genet.
2011;
7
(6):
e1002153
-
Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.
Chu C,
Qu K, Zhong FL, Artandi SE, Chang HY.
Mol Cell.
2011;
44
(4):
667-78
-
Long intergenic noncoding RNAs: new links in cancer progression.
Tsai MC,
Spitale RC, Chang HY.
Cancer Res.
2011;
71
(1):
3-7
-
Long noncoding RNAs and human disease.
Wapinski O,
Chang HY.
Trends Cell Biol.
2011;
21
(6):
354-61
-
Molecular mechanisms of long noncoding RNAs.
Wang KC,
Chang HY.
Mol Cell.
2011;
43
(6):
904-14
-
RNA templating the epigenome: long noncoding RNAs as molecular scaffolds.
Spitale RC,
Tsai MC, Chang HY.
Epigenetics.
2011;
6
(5):
539-43
-
Understanding the transcriptome through RNA structure.
Wan Y,
Kertesz M, Spitale RC, Segal E, Chang HY.
Nat Rev Genet.
2011;
12
(9):
641-55
-
Long noncoding RNA in genome regulation: prospects and mechanisms.
Hung T,
Chang HY.
RNA Biol.
2010 Sep-Oct;
7
(5):
582-5
-
G1 arrest and differentiation can occur independently of Rb family function.
Wirt SE,
Adler AS, Gebala V, Weimann JM, Schaffer BE, Saddic LA, Viatour P, Vogel H, Chang HY, Meissner A, Sage J.
J Cell Biol.
2010;
191
(4):
809-25
-
Genome-wide measurement of RNA secondary structure in yeast.
Kertesz M,
Wan Y, Mazor E, Rinn JL, Nutter RC, Chang HY, Segal E.
Nature.
2010;
467
(7311):
103-7
-
HOTAIR: Flight of noncoding RNAs in cancer metastasis.
Wan Y,
Chang HY.
Cell Cycle.
2010;
9
(17):
3391-2
-
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
Gupta RA,
Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY.
Nature.
2010;
464
(7291):
1071-6
-
Long noncoding RNA as modular scaffold of histone modification complexes.
Tsai MC,
Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY.
Science.
2010;
329
(5992):
689-93
-
Noncoding RNA landmarks of pluripotency and reprogramming.
Ouyang Z,
Zheng GX, Chang HY.
Cell Stem Cell.
2010;
7
(6):
649-50
-
The histone demethylase UTX enables RB-dependent cell fate control.
Wang JK,
Tsai MC, Poulin G, Adler AS, Chen S, Liu H, Shi Y, Chang HY.
Genes Dev.
2010;
24
(4):
327-32
-
Tumor suppression by the histone demethylase UTX.
Tsai MC,
Wang JK, Chang HY.
Cell Cycle.
2010;
9
(11):
2043-4
-
Anatomic demarcation of cells: genes to patterns.
Chang HY,
Science.
2009;
326
(5957):
1206-7
-
Gene dates, parties and galas. Symposium on Chromatin Dynamics and Higher Order Organization.
Chang HY,
Cuvier O, Dekker J.
EMBO Rep.
2009;
10
(7):
689-93
-
Genome-wide views of chromatin structure.
Rando OJ,
Chang HY.
Annu Rev Biochem.
2009:
78
245-71
-
Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.
Somervaille TC,
Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM, Chang HY, Shurtleff SA, Downing JR, Cleary ML.
Cell Stem Cell.
2009;
4
(2):
129-40
-
ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation.
Hung T,
Binda O, Champagne KS, Kuo AJ, Johnson K, Chang HY, Simon MD, Kutateladze TG, Gozani O.
Mol Cell.
2009;
33
(2):
248-56
-
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.
Chan KS,
Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL.
Proc Natl Acad Sci U S A.
2009;
106
(33):
14016-21
-
Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression.
Reuter JA,
Ortiz-Urda S, Kretz M, Garcia J, Scholl FA, Pasmooij AM, Cassarino D, Chang HY, Khavari PA.
Cancer Cell.
2009;
15
(6):
477-88
-
Molecular framework for response to imatinib mesylate in systemic sclerosis.
Chung L,
Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL, Whitfield ML, Chang HY, Robinson WH.
Arthritis Rheum.
2009;
60
(2):
584-91
-
Regeneration, repair and remembering identity: the three Rs of Hox gene expression.
Wang KC,
Helms JA, Chang HY.
Trends Cell Biol.
2009;
19
(6):
268-75
-
SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span.
Kawahara TL,
Michishita E, Adler AS, Damian M, Berber E, Lin M, McCord RA, Ongaigui KC, Boxer LD, Chang HY, Chua KF.
Cell.
2009;
136
(1):
62-74
-
Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment.
Chan DA,
Kawahara TL, Sutphin PD, Chang HY, Chi JT, Giaccia AJ.
Cancer Cell.
2009;
15
(6):
527-38
-
A dermal HOX transcriptional program regulates site-specific epidermal fate.
Rinn JL,
Wang JK, Allen N, Brugmann SA, Mikels AJ, Liu H, Ridky TW, Stadler HS, Nusse R, Helms JA, Chang HY.
Genes Dev.
2008;
22
(3):
303-7
-
A systems biology approach to anatomic diversity of skin.
Rinn JL,
Wang JK, Liu H, Montgomery K, van de Rijn M, Chang HY.
J Invest Dermatol.
2008;
128
(4):
776-82
-
CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
Adler AS,
Littlepage LE, Lin M, Kawahara TL, Wong DJ, Werb Z, Chang HY.
Cancer Res.
2008;
68
(2):
506-15
-
Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.
Nuyten DS,
Hastie T, Chi JT, Chang HY, van de Vijver MJ.
Eur J Cancer.
2008;
44
(15):
2319-29
-
Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3.
Sen GL,
Webster DE, Barragan DI, Chang HY, Khavari PA.
Genes Dev.
2008;
22
(14):
1865-70
-
Deletional tolerance mediated by extrathymic Aire-expressing cells.
Gardner JM,
Devoss JJ, Friedman RS, Wong DJ, Tan YX, Zhou X, Johannes KP, Su MA, Chang HY, Krummel MF, Anderson MS.
Science.
2008;
321
(5890):
843-7
-
Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes.
Sääf AM,
Tengvall-Linder M, Chang HY, Adler AS, Wahlgren CF, Scheynius A, Nordenskjöld M, Bradley M.
PLoS One.
2008;
3
(12):
e4017
-
Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire.
Su MA,
Giang K, Zumer K, Jiang H, Oven I, Rinn JL, Devoss JJ, Johannes KP, Lu W, Gardner J, Chang A, Bubulya P, Chang HY, Peterlin BM, Anderson MS.
J Clin Invest.
2008;
118
(5):
1712-26
-
Module map of stem cell genes guides creation of epithelial cancer stem cells.
Wong DJ,
Liu H, Ridky TW, Cassarino D, Segal E, Chang HY.
Cell Stem Cell.
2008;
2
(4):
333-44
-
Revealing targeted therapy for human cancer by gene module maps.
Wong DJ,
Nuyten DS, Regev A, Lin M, Adler AS, Segal E, van de Vijver MJ, Chang HY.
Cancer Res.
2008;
68
(2):
369-78
-
Reversal of aging by NFkappaB blockade.
Adler AS,
Kawahara TL, Segal E, Chang HY.
Cell Cycle.
2008;
7
(5):
556-9
-
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.
Michishita E,
McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, Chua KF.
Nature.
2008;
452
(7186):
492-6
-
Stemness, cancer and cancer stem cells.
Wong DJ,
Segal E, Chang HY.
Cell Cycle.
2008;
7
(23):
3622-4
-
Systematic functional characterization of cis-regulatory motifs in human core promoters.
Sinha S,
Adler AS, Field Y, Chang HY, Segal E.
Genome Res.
2008;
18
(3):
477-88
-
A histone H3 lysine 27 demethylase regulates animal posterior development.
Lan F,
Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E, Roberts TM, Chang HY, Shi Y.
Nature.
2007;
449
(7163):
689-94
-
A transcriptional program mediating entry into cellular quiescence.
Liu H,
Adler AS, Segal E, Chang HY.
PLoS Genet.
2007;
3
(6):
e91
-
Decoding global gene expression programs in liver cancer by noninvasive imaging.
Segal E,
Sirlin CB, Ooi C, Adler AS, Gollub J, Chen X, Chan BK, Matcuk GR, Barry CT, Chang HY, Kuo MD.
Nat Biotechnol.
2007;
25
(6):
675-80
-
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.
Rinn JL,
Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY.
Cell.
2007;
129
(7):
1311-23
-
GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN.
Huang W,
Chang HY, Fei T, Wu H, Chen YG.
Oncogene.
2007;
26
(17):
2471-82
-
Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs.
O'Geen H,
Squazzo SL, Iyengar S, Blahnik K, Rinn JL, Chang HY, Green R, Farnham PJ.
PLoS Genet.
2007;
3
(6):
e89
-
Motif module map reveals enforcement of aging by continual NF-kappaB activity.
Adler AS,
Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY.
Genes Dev.
2007;
21
(24):
3244-57
-
Patterning skin pigmentation via dickkopf.
Chang HY,
J Invest Dermatol.
2007;
127
(5):
994-5
-
Turning skin into embryonic stem cells.
Chang HY,
Cotsarelis G.
Nat Med.
2007;
13
(7):
783-4
-
Anatomic demarcation by positional variation in fibroblast gene expression programs.
Rinn JL,
Bondre C, Gladstone HB, Brown PO, Chang HY.
PLoS Genet.
2006;
2
(7):
e119
-
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
Sneddon JB,
Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO.
Proc Natl Acad Sci U S A.
2006;
103
(40):
14842-7
-
From description to causality: mechanisms of gene expression signatures in cancer.
Adler AS,
Chang HY.
Cell Cycle.
2006;
5
(11):
1148-51
-
Genetic regulators of large-scale transcriptional signatures in cancer.
Adler AS,
Lin M, Horlings H, Nuyten DS, van de Vijver MJ, Chang HY.
Nat Genet.
2006;
38
(4):
421-30
-
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species.
Ray S,
Atkuri KR, Deb-Basu D, Adler AS, Chang HY, Herzenberg LA, Felsher DW.
Cancer Res.
2006;
66
(13):
6598-605
-
Microarray analysis of stem cells and differentiation.
Chang HY,
Thomson JA, Chen X.
Methods Enzymol.
2006:
420
225-54
-
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
Nuyten DS,
Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY, van de Vijver MJ.
Breast Cancer Res.
2006;
8
(5):
R62
-
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen.
DeVoss J,
Hou Y, Johannes K, Lu W, Liou GI, Rinn J, Chang H, Caspi RR, Caspi R, Fong L, Anderson MS.
J Exp Med.
2006;
203
(12):
2727-35
-
Learning more from microarrays: insights from modules and networks.
Wong DJ,
Chang HY.
J Invest Dermatol.
2005;
125
(2):
175-82
-
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.
Chang HY,
Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ.
Proc Natl Acad Sci U S A.
2005;
102
(10):
3738-43
-
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.
Chang HY,
Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO.
PLoS Biol.
2004;
2
(2):
E7
-
Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis.
Chang HY,
Cooper ZA, Swetter SM, Marinkovich MP.
Arch Dermatol.
2004;
140
(2):
242-4
-
Endothelial cell diversity revealed by global expression profiling.
Chi JT,
Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO.
Proc Natl Acad Sci U S A.
2003;
100
(19):
10623-8
-
Eruptive xanthomas associated with olanzapine use.
Chang HY,
Ridky TW, Kimball AB, Hughes E, Oro AE.
Arch Dermatol.
2003;
139
(8):
1045-8
-
Genomewide view of gene silencing by small interfering RNAs.
Chi JT,
Chang HY, Wang NN, Chang DS, Dunphy N, Brown PO.
Proc Natl Acad Sci U S A.
2003;
100
(11):
6343-6
-
Myelogenous leukemia cutis resembling stasis dermatitis.
Chang HY,
Wong KM, Bosenberg M, McKee PH, Haynes HA.
J Am Acad Dermatol.
2003;
49
(1):
128-9
-
Diversity, topographic differentiation, and positional memory in human fibroblasts.
Chang HY,
Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO.
Proc Natl Acad Sci U S A.
2002;
99
(20):
12877-82
-
Proteases for cell suicide: functions and regulation of caspases.
Chang HY,
Yang X.
Microbiol Mol Biol Rev.
2000;
64
(4):
821-46
-
Dissecting Fas signaling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation.
Chang HY,
Yang X, Baltimore D.
Proc Natl Acad Sci U S A.
1999;
96
(4):
1252-6
-
Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx.
Chang HY,
Nishitoh H, Yang X, Ichijo H, Baltimore D.
Science.
1998;
281
(5384):
1860-3
-
Autoproteolytic activation of pro-caspases by oligomerization.
Yang X,
Chang HY, Baltimore D.
Mol Cell.
1998;
1
(2):
319-25
-
Essential role of CED-4 oligomerization in CED-3 activation and apoptosis.
Yang X,
Chang HY, Baltimore D.
Science.
1998;
281
(5381):
1355-7
-
Daxx, a novel Fas-binding protein that activates JNK and apoptosis.
Yang X,
Khosravi-Far R, Chang HY, Baltimore D.
Cell.
1997;
89
(7):
1067-76
-
Activation of CLN1 and CLN2 G1 cyclin gene expression by BCK2.
Di Como CJ,
Chang H, Arndt KT.
Mol Cell Biol.
1995;
15
(4):
1835-46
-
Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin.
Chang HY,
Takei K, Sydor AM, Born T, Rusnak F, Jay DG.
Nature.
1995;
376
(6542):
686-90
-
Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition.
Zydowsky LD,
Etzkorn FA, Chang HY, Ferguson SB, Stolz LA, Ho SI, Walsh CT.
Protein Sci.
1992;
1
(9):
1092-9
-
Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B.
Swanson SK,
Born T, Zydowsky LD, Cho H, Chang HY, Walsh CT, Rusnak F.
Proc Natl Acad Sci U S A.
1992;
89
(9):
3741-5
Help